Skip to content
Therapy But Better – Lifestyle
Author:
CureGene
CureGene Achieves First Participant Dosed in U.S. Pivotal Trial for Evategrel (CG-0255), a Best-in-Class Antiplatelet Drug, Accelerating Global Commercialization
June 20, 2026